Controlling monoclonal antibody aggregation during cell culture using medium additives facilitated by the monitoring of aggregation in cell culture matrix using size exclusion chromatography

被引:4
作者
Kumari, Prity [1 ]
Saldanha, Marianne [2 ]
Jain, Ratnesh [2 ]
Dandekar, Prajakta [1 ]
机构
[1] Inst Chem Technol, Dept Pharmaceut Sci & Technol, Mumbai 400019, India
[2] Inst Chem Technol, Dept Biol Sci & Biotechnol, Mumbai 400019, India
关键词
Monoclonal antibody; Aggregation; CHO cell culture; Medium additives; Size exclusion chromatography; PROTEIN AGGREGATION; IMPROVEMENT; METABOLISM; TREHALOSE; MANNOSE; GLUCOSE;
D O I
10.1016/j.jpba.2023.115575
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Controlling monoclonal antibody aggregation at the upstream stage itself can significantly reduce the burden on downstream processing and can improve the process yield. Hence, we have investigated the use of sugar osmolytes (glucose, mannose, sucrose and maltose) and formulation excipients (mannitol, polysorbate 20 and polysorbate 80) as medium additives to reduce protein aggregation during cell culture. Aggregate content in cell culture samples was estimated using a high-resolution size-exclusion chromatography technique, which efficiently resolved the antibody monomer and aggregates in the cell culture matrix i.e., without purification. Glucose, mannose, maltose and the polysorbates effectively reduced the mean aggregate content over the course of the culture. Sugar-based additives exhibited a higher degree of variation during aggregate quantitation as compared to polysorbate additives, rendering the latter a preferred additive. Therefore, this study demonstrated the potential of sugar osmolytes and formulation excipients as media additives during cell culture to reduce aggregate formation, without negatively impacting cell growth and antibody production, facilitated by the monitoring of aggregate content in cell culture samples without purification.
引用
收藏
页数:9
相关论文
共 42 条
[1]  
agilent, ADVANCEBIO SECT 2 7
[2]   Improvement of CHO cell culture medium formulation:: Simultaneous substitution of glucose and glutamine [J].
Altamirano, C ;
Paredes, C ;
Cairó, JJ ;
Gòdia, F .
BIOTECHNOLOGY PROGRESS, 2000, 16 (01) :69-75
[3]   The Critical Role of Mobile Phase Composition in Size Exclusion Chromatography of Protein Pharmaceuticals [J].
Arakawa, Tsutomu ;
Ejima, Daisuke ;
Li, Tiansheng ;
Phil, John S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (04) :1674-1692
[4]   Continuous CHO cell cultures with improved recombinant protein productivity by using mannose as carbon source: Metabolic analysis and scale-up simulation [J].
Berrios, Julio ;
Altamirano, Claudia ;
Osses, Nelson ;
Gonzalez, Ramon .
CHEMICAL ENGINEERING SCIENCE, 2011, 66 (11) :2431-2439
[5]   Monoclonal antibody therapeutics: history and future [J].
Buss, Nicholas A. P. S. ;
Henderson, Simon J. ;
McFarlane, Mary ;
Shenton, Jacintha M. ;
de Haan, Lolke .
CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (05) :615-622
[6]   Rapid two-dimensional Protein-A size exclusion chromatography of monoclonal antibodies for titer and aggregation measurements from harvested cell culture fluid samples [J].
Dunn, Zachary D. ;
Desai, Jayesh ;
Leme, Gabriel M. ;
Stoll, Dwight R. ;
Richardson, Douglas D. .
MABS, 2020, 12 (01)
[7]   Advances in liquid formulations of parenteral therapeutic proteins [J].
Falconer, Robert J. .
BIOTECHNOLOGY ADVANCES, 2019, 37 (07)
[8]   Amino Acid and Glucose Metabolism in Fed-Batch CHO Cell Culture Affects Antibody Production and Glycosylation [J].
Fan, Yuzhou ;
Del Val, Ioscani Jimenez ;
Mueller, Christian ;
Sen, Jette Wagtberg ;
Rasmussen, Soren Kofoed ;
Kontoravdi, Cleo ;
Weilguny, Dietmar ;
Andersen, Mikael Rordam .
BIOTECHNOLOGY AND BIOENGINEERING, 2015, 112 (03) :521-535
[9]  
FDA, 2002, HUMIRA AD INJ SUBC U
[10]  
FDA, 2014, OPDIVO NIV INJ INTR